Article
CRISPR-Cas13a Inhibits HIV-1 Infection
1 Jun 2020
Abstract excerpt
CRISPR-Cas provides bacteria and archaea with immunity against invading phages and foreign plasmid DNA and has been successfully adapted for gene editing in a variety of species. The class 2 type VI CRISPR-Cas effector Cas13a targets and cleaves RNA, providing protection against RNA phages. Here we report the repurposing of CRISPR-Cas13a to inhibit human immunodeficiency virus type 1 (HIV-1) infection through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
